Previous Close | 2.1800 |
Open | 2.2100 |
Bid | 2.1700 x 500 |
Ask | 2.2000 x 300 |
Day's Range | 2.1640 - 2.2300 |
52 Week Range | 2.1000 - 4.3000 |
Volume | |
Avg. Volume | 490,126 |
Market Cap | 217.18M |
Beta (5Y Monthly) | 1.47 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin. To see more such companies, go directly to 5 Best Penny Stocks to Buy According to Billionaire Ken Griffin. The markets were off to an impressive start in 2024, driven by expectations that the […]
If you love investing in stocks you're bound to buy some losers. But the long term shareholders of Accuray Incorporated...